INVITROGEN has announced the availability of its PlexMark 3 Renal Biomarker Panel Assay which has been developed as a new biomarker tool for use in pre-clinical research into kidney function.
Invitrogen says the PlexMark 3 is a non-invasive research tool designed to perform kidney function post-transplantation studies rapidly and easily.
The PlexMark provides researchers with an alternative to invasive procedures such as biopsies used to obtain kidney tissue samples to allow for research into kidney function, post-transplantation.
Invitrogen says the PlexMark 3 Renal Biomarker Panel Assay measures levels of cytokines, chemokines and receptor levels in urine, which enable researchers to better understand immune function and response.
Additionally, the PlexMark assay uses Luminex xMAP multiplexing technology for bioassay analysis, in a standard immunoassay format to offer rapid, reproducible results.
Add your comments